GnIH secreted by green light exposure, regulates bone mass through the activation of Gpr147

Abstract

Reproductive hormones associated with the hypothalamic-pituitary-gonadal (HPG) axis are closely linked to bone homeostasis. In this study, we demonstrate that Gonadotropin inhibitory hormone (GnIH, one of the key reproductive hormones upstream of the HPG axis) plays an indispensable role in regulating bone homeostasis and maintaining bone mass. We find that deficiency of GnIH or its receptor Gpr147 leads to a significant reduction in bone mineral density (BMD) in mice primarily by enhancement of osteoclast activation in vivo and in vitro. Mechanistically, GnIH/Gpr147 inhibits osteoclastogenesis by the PI3K/AKT, MAPK, NF-κB and Nfatc1 signaling pathways. Furthermore, GnIH treatment was able to alleviate bone loss in aging, ovariectomy (OVX) or LPS-induced mice. Moreover, the therapy using green light promotes the release of GnIH and rescues OVX-induced bone loss. In humans, serum GnIH increases and bone resorption markers decrease after green light exposure. Therefore, our study elucidates that GnIH plays an important role in maintaining bone homeostasis via modulating osteoclast differentiation and demonstrates the potential of GnIH therapy or green light therapy in preventing osteoporosis.

References

[1.] Feng X, McDonald JM. Disorders of bone remodeling Annu. Rev. Pathol., 2011, 6: 121-145.

[2.] Yamaguchi M. Role of carotenoid β-cryptoxanthin in bone homeostasis J. Biomed. Sci., 2012, 19: 36.

[3.] Zhu Q, et al.. OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2 Signal Transduct. Target Ther., 2023, 8: 142.

[4.] Li C, et al.. The osteoprotective role of USP26 in coordinating bone formation and resorption Cell Death Differ., 2022, 29: 1123-1136.

[5.] Li Z, et al.. Dual targeting of bile acid receptor-1 (TGR5) and farnesoid X receptor (FXR) prevents estrogen-dependent bone loss in mice J. Bone Miner. Res., 2019, 34: 765-776.

[6.] Luo J, et al.. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption Nat. Med., 2016, 22: 539-546.

[7.] Sun P, et al.. Regulation of body length and bone mass by Gpr126/Adgrg6 Sci. Adv., 2020, 6. eaaz0368

[8.] Mills EG, et al.. The relationship between bone and reproductive hormones beyond estrogens and androgens Endocr. Rev., 2021, 42: 691-719.

[9.] Tsutsui K, Ubuka T. Gonadotropin-inhibitory hormone (GnIH): a new key neurohormone controlling reproductive physiology and behavior Front. Neuroendocrinol., 2021, 61. 100900

[10.] Yeh JK, Chen MM, Aloia JF. Ovariectomy-induced high turnover in cortical bone is dependent on pituitary hormone in rats Bone, 1996, 18: 443-450.

[11.] Yeh JK, Chen MM, Aloia JF. Effects of 17 beta-estradiol administration on cortical and cancellous bone of ovariectomized rats with and without hypophysectomy Bone, 1997, 20: 413-420.

[12.] Wu XY, et al.. Early bone mineral density decrease is associated with FSH and LH, not estrogen Clin. Chim. Acta, 2013, 415: 69-73.

[13.] Maggi R, et al.. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system Hum. Reprod. Update, 2016, 22: 358-381.

[14.] Brommage R, et al.. High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes Bone Res., 2014, 2. 14034

[15.] Jiang C, Qi L, Xue J, Wang Y. Indirubin-3’-oxime promotes the efficacy of GnRHa in obese-induced central precocious puberty and maintains normal bone growth and body weight via the ERK-Sp1-KISS-1/GPR54 axis Cell Mol. Biol., 2023, 69: 188-194.

[16.] Allan CM, et al.. Follicle-stimulating hormone increases bone mass in female mice Proc. Natl. Acad. Sci. USA, 2010, 107: 22629-22634.

[17.] Divasta AD, Laufer MR, Gordon CM. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis J. Pediatr. Adolesc. Gynecol., 2007, 20: 293-297.

[18.] Rothman MS, Wierman ME. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes Curr. Opin. Endocrinol. Diab. Obes., 2007, 14: 306-310.

[19.] Sauerbrun-Cutler MT, Alvero R. Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture Fertil. Steril., 2019, 112: 799-803.

[20.] Sun L, et al.. FSH directly regulates bone mass Cell, 2006, 125: 247-260.

[21.] Talbi R, Navarro VM. Novel insights into the metabolic action of Kiss1 neurons Endocr. Connect, 2020, 9: R124-R133.

[22.] Celik O, et al.. Ghrelin action on GnRH neurons and pituitary gonadotropes might be mediated by GnIH-GPR147 system Horm. Mol. Biol. Clin. Investig., 2016, 25: 121-128.

[23.] Singh P, Anjum S, Srivastava RK, Tsutsui K, Krishna A. Central and peripheral neuropeptide RFRP-3: A bridge linking reproduction, nutrition, and stress response Front. Neuroendocrinol., 2022, 65. 100979

[24.] Tsutsui K, Ubuka T, Bentley GE, Kriegsfeld LJ. Gonadotropin-inhibitory hormone (GnIH): discovery, progress and prospect Gen. Comp. Endocrinol., 2012, 177: 305-314.

[25.] Ubuka T, Bentley GE, Ukena K, Wingfield JC, Tsutsui K. Melatonin induces the expression of gonadotropin-inhibitory hormone in the avian brain Proc. Natl. Acad. Sci. USA, 2005, 102: 3052-3057.

[26.] Luo R, et al.. Possible role of GnIH as a novel link between hyperphagia-induced obesity-related metabolic derangements and hypogonadism in male mice Int. J. Mol. Sci., 2022, 23: 8066.

[27.] Tsutsui K, et al.. Gonadotropin-inhibitory hormone (GnIH) and its control of central and peripheral reproductive function Front. Neuroendocrinol., 2010, 31: 284-295.

[28.] Tsutsui K, Ubuka T. GnIH control of feeding and reproductive behaviors Front. Endocrinol., 2016, 7: 170.

[29.] Tsutsui K, Ubuka T, Ukena K. Advancing reproductive neuroendocrinology through research on the regulation of GnIH and on its diverse actions on reproductive physiology and behavior Front. Neuroendocrinol., 2022, 64. 100955

[30.] Gojska NM, Belsham DD. Glucocorticoid receptor-mediated regulation of Rfrp (GnIH) and Gpr147 (GnIH-R) synthesis in immortalized hypothalamic neurons Mol. Cell Endocrinol., 2014, 384: 23-31.

[31.] Poling MC, Kauffman AS. Regulation and function of RFRP-3 (GnIH) neurons during postnatal development Front. Endocrinol., 2015, 6: 150.

[32.] Tsutsui K. A new key neurohormone controlling reproduction, gonadotropin-inhibitory hormone (GnIH): Biosynthesis, mode of action and functional significance Prog. Neurobiol., 2009, 88: 76-88.

[33.] Tsutsui K, Ubuka T. Discovery of gonadotropin-inhibitory hormone (GnIH), progress in GnIH research on reproductive physiology and behavior and perspective of GnIH research on neuroendocrine regulation of reproduction Mol. Cell Endocrinol., 2020, 514. 110914

[34.] Ubuka T, Son YL, Tobari Y, Tsutsui K. Gonadotropin-inhibitory hormone action in the brain and pituitary Front. Endocrinol., 2012, 3: 148.

[35.] Mittan D, et al.. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs J. Clin. Endocrinol. Metab., 2002, 87: 3656-3661.

[36.] Zhang L, et al.. Green light inhibits GnRH-I expression by stimulating the melatonin-GnIH pathway in the chick brain J Neuroendocrinol., 2017, 29: 1-15.

[37.] Zhu HX, et al.. Effect and molecular regulatory mechanism of monochromatic light colors on the egg-laying performance of Yangzhou geese Anim. Reprod. Sci., 2019, 204: 131-139.

[38.] Tang YL, et al.. Green light analgesia in mice is mediated by visual activation of enkephalinergic neurons in the ventrolateral geniculate nucleus Sci. Transl. Med., 2022, 14. eabq6474

[39.] Cui J, et al.. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway J. Cell Mol. Med., 2020, 24: 6149-6161.

[40.] Qian Z, et al.. Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis J. Cell Mol. Med., 2020, 24: 10112-10127.

[41.] Xin Y, et al.. New Function of RUNX2 in Regulating Osteoclast Differentiation via the AKT/NFATc1/CTSK Axis Calcif. Tissue Int., 2020, 106: 553-566.

[42.] Yang S, et al.. AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis Int. Immunopharmacol., 2022, 113. 109370

[43.] Kovtonyuk LV, et al.. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice Blood, 2022, 139: 44-58.

[44.] Cui J, Fu Y, Yi Z, Dong C, Liu H. The beneficial effects of ultraviolet light supplementation on bone density are associated with the intestinal flora in rats Appl. Microbiol. Biotechnol., 2021, 105: 3705-3715.

[45.] Kimlin MG. Geographic location and vitamin D synthesis Mol. Asp. Med., 2008, 29: 453-461.

[46.] Lu Y, Yang J, Dong C, Fu Y, Liu H. Gut microbiome-mediated changes in bone metabolism upon infrared light exposure in rats J. Photochem. Photobio. B, 2021, 217. 112156

[47.] Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer Int. J. Dermatol., 2010, 49: 978-986.

[48.] Bergamaschi A, Grandi C, D’Addato M, Di Carlo V, Russo A. Health risks from infrared emissions from radiant tube heaters in the workplace] G Ital. Med. Lav., 1995, 17: 41-49

[49.] Christensen T, Kinn G, Granli T, Amundsen I. Cells, bilirubin and light: formation of bilirubin photoproducts and cellular damage at defined wavelengths Acta Paediatr., 1994, 83: 7-12.

[50.] Rachner TD, Coleman R, Hadji P, Hofbauer LC. Bone health during endocrine therapy for cancer Lancet Diab. Endocrinol., 2018, 6: 901-910.

[51.] Tsutsui K, Son YL, Kiyohara M, Miyata I. Discovery of GnIH and its role in hypothyroidism-induced delayed puberty Endocrinology, 2018, 159: 62-68.

[52.] Jensen TL, Kiersgaard MK, Sørensen DB, Mikkelsen LF. Fasting of mice: a review Lab. Anim., 2013, 47: 225-240.

[53.] Wetterberg L. Light and biological rhythms J. Intern. Med., 1994, 235: 5-19.

[54.] Brown TM, et al.. Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults PLoS Biol., 2022, 20: e3001571.

[55.] Jiang W, et al.. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis Bone Res., 2022, 10: 27.

[56.] Yue Z, et al.. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis J. Clin. Invest., 2022, 132: e144579.

[57.] Hou GQ, et al.. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells Int. J. Mol. Med., 2013, 32: 503-510.

[58.] Mao JY, et al.. Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients J. Diab. Complications, 2017, 31: 1538-1543.

[59.] Zhu Y, Liu Z, Peng YP, Qiu YH. Interleukin-10 inhibits neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway Int. Immunopharmacol., 2017, 50: 353-360.

[60.] Sharma K, et al.. Chebulinic acid alleviates LPS-induced inflammatory bone loss by targeting the crosstalk between reactive oxygen species/NFκB signaling in osteoblast cells Free Radic. Biol. Med., 2023, 194: 99-113.

[61.] Constantin S, et al.. An inhibitory circuit from brainstem to GnRH neurons in male mice: a new role for the RFRP Receptor Endocrinology, 2021, 162: bqab030.

[62.] Huo K, et al.. RFRP-3, the mammalian ortholog of GnIH, is a novel modulator involved in food intake and glucose homeostasis Front. Endocrinol., 2020, 11: 194.

[63.] Ullah R, et al.. Gonadotropin inhibitory hormone and RF9 stimulate hypothalamic-pituitary-adrenal axis in adult male rhesus monkeys Neuropeptides, 2017, 66: 1-7.

[64.] An K, et al.. A circadian rhythm-gated subcortical pathway for nighttime-light-induced depressive-like behaviors in mice Nat. Neurosci., 2020, 23: 869-880.

[65.] He L, et al.. GPRC5B protects osteoarthritis by regulation of autophagy signaling Acta Pharm. Sin. B, 2023, 13: 2976-2989.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(92168204); Fundamental Research Funds for the Central Universities 22120210586 National Key Research and Development Program of China 2023YFB3810200